ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,968Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 392

$656K Total Retail Price of All Prescriptions

Rank: 6 out of 392

495 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
62% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Hampshire
Lower avg

Schedule Two
Controlled Substances

22% of this provider’s 495 patients filled at least one prescription for a schedule two drug, compared to an average of 8%.

Schedule Three
Controlled Substances

13% of this provider’s 495 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

2% of this provider’s 5,087 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $62 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Hampshire
LISINOPRIL 459 277 1 1
SIMVASTATIN 424 323 2 2
FUROSEMIDE 255 197 3 6
METFORMIN HCL 240 151 4 9
LEVOTHYROXINE SODIUM 231 169 5 3
AMLODIPINE BESYLATE 221 187 6 5
OXYCODONE HCL 219 25 S2 7 16
METOPROLOL TARTRATE 210 165 8 8
HYDROCODONE-ACETAMINOPHEN 176 57 S3 9 14
OMEPRAZOLE 146 56 10 4
LOSARTAN POTASSIUM 140 89 11 20
WARFARIN SODIUM 133 105 12 12
PROAIR HFA 124 47 13 36
OXYCONTIN 120 22 S2 14 49
HYDROCHLOROTHIAZIDE 116 88 15 7
ATORVASTATIN CALCIUM 115 77 16 10
ZOLPIDEM TARTRATE 115 61 16 21
METOPROLOL SUCCINATE 110 56 18 13
TAMSULOSIN HCL 102 92 19 37
CYMBALTA 96 44 20 52
TRAMADOL HCL 96 47 20 25
ATENOLOL 86 59 22 11
CRESTOR 85 60 23 27
IBUPROFEN 85 24 23 64
ADVAIR DISKUS 84 69 25 32
TRAZODONE HCL 81 13 26 22
GABAPENTIN 75 44 27 18
CARISOPRODOL 73 0 R 28 152
GEMFIBROZIL 71 37 29 79
LISINOPRIL-HYDROCHLOROTHIAZIDE 70 63 30 34
PANTOPRAZOLE SODIUM 69 34 31 24
LOVASTATIN 68 53 32 23
CLOPIDOGREL 66 36 33 70
SERTRALINE HCL 66 40 33 19
PRAVASTATIN SODIUM 66 47 33 17
OXYCODONE-ACETAMINOPHEN 64 22 S2 36 33
OXYCODONE HCL-ACETAMINOPHEN 62 0 S2 37 78
NEXIUM 62 31 37 28
METHADONE HCL 61 0 S2 39 65
ALLOPURINOL 59 48 40 38
OLANZAPINE 57 0 41 95
DILTIAZEM 24HR ER 54 50 42 107
CELEBREX 53 29 43 80
TERAZOSIN HCL 53 53 43 92
LANTUS SOLOSTAR 51 16 45 88
CYCLOBENZAPRINE HCL 51 13 R 45 46
AZITHROMYCIN 50 22 47 74
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 16, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.